SC
ETNB

Sagefield Capital’s 89bio ETNB Stock Holding History

Sagefield Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,300
Closed -$1.3M – 112
2025
Q3 		$1.3M Buy
+88,300
New +$900K 0.15% 84

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sagefield Capital's ETNB Position: Q4 2025 in Review

Sagefield Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 88,300 shares — an estimated $1.3M sold.

Sagefield Capital first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $1.3M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Sagefield Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Sagefield Capital sold 88,300 89bio shares in Q4 2025, an estimated $1.3M.
  • Sagefield Capital first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Sagefield Capital's 89bio position peaked at $1.3M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Sagefield Capital's 13F filing for Q4 2025, filed 17 Feb 2026.